esophageal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Age 18-75 years old, gender is not limited; (2) Definite diagnosis of malignant pathology; (3) The primary tumor was located in the middle and lower esophagus. Referring to the 8th TNM staging system of the Union for International Cancer Control (UICC)/American Joint Committee on Cancer (AJCC), The cTNM stages were T1b-2, N0 and M0. (4) Be able to cooperate with and complete follow-up and related examinations; (5) Voluntarily participate in this experiment and sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with severe cardiovascular and cerebrovascular diseases or serious heart, lung, liver, kidney and other major organ dysfunction, unable to tolerate anesthesia or surgical operations. (2) Patients with severe coagulation disorders. (3) Obese people (BMI> 40). (4) Severe and uncontrolled hypertension, diabetes, blood system disease, or immune system disease. (5) Combined with surgical site or systemic infection, severe inflammatory reaction. (6) Patients with ascites or ascites caused by esophageal cancer, with obvious signs of external invasion and perforation (such as hoarseness, coughing, etc.). (7) Pregnant, menstrual or breastfeeding women. (8) The ASA score is greater than grade II. (9) Patients with severe mental illness who cannot cooperate. (10) Participants in other investigational drug or device clinical trials have not been completed. (11) Patients considered unsuitable for participation in this project by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Surgical non-conversion rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of lymph node dissection;Patient VAS score;Postoperative hospital stay;Surgeon satisfaction; | — |
Countries
China
Contacts
Harbin Medical University Cancer Hospital, 150 Haping Road, Nan'gang District, Harbin, Heilongjiang